Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-11-03 | Amended | $26,195,278 | $2,312,070 | Equity Only | 06b | SEC link |
| 2025-04-18 | Amended | $23,883,208 | $7,773,417 | Equity Only | 06b | SEC link |
| 2023-11-01 | New | $16,109,791 | $16,109,791 | Equity Only | 06b | SEC link |
| 2020-12-11 | New | $2,500,000 | $2,500,000 | Debt Only | 06b | SEC link |
| 2019-10-11 | New | $6,644,601 | $6,644,601 | Equity Only | 06b | SEC link |
| 2017-03-07 | New | $2,650,566 | $2,650,566 | Debt Only | 06b | SEC link |
| 2017-02-10 | New | $2,327,991 | $2,327,991 | Equity Only | 06b | SEC link |
| 2015-07-16 | New | $2,060,000 | $2,060,000 | Debt Only | 06b | SEC link |
| 2013-01-08 | New | $2,079,992 | $2,079,992 | Equity Only | 06 | SEC link |
| 2012-11-14 | New | $330,000 | $330,000 | Debt Only | 06 | SEC link |
| Name | Role |
|---|---|
| Daniel Adams | Director |
| Gavin Christensen | Director |
| Kent Savage | Director, Executive |
| Henry, Jr. Savage | Director, Executive |
| Ted Stanley | Director |